(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HAISCO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

HAISCO

ST13

US500000079262491

Class

5, 10, 35

Filing

79262491

Registration

6061075

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

05/27/2025

Trademark type

Combined

Nice classes

5, 10, 35

Filing date

05/24/2019

Registration date

05/26/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/26/2020

Last transaction

05/27/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

03

Owner location

CN

Examiner

BRADLEY, EVELYN

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "HAISCO" with a polygon with curved sides.

Holders and representatives

Holders

Haisco Pharmaceutical Group Co., Ltd.
HAISCO PHARMACEUTICAL GROUP CO.

Representatives

Willy H. Wong Minder Law Group

Technical classification

Nice Classes

Class 5Class 10Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for human purposesspecifically for the treating or prevention of hepatopathyneoplasmcancertumorsneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseasesfor use in surgery; biological preparation for medical purposesspecifically for the treatment of hepatopathyneoplasmcancertumorsneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseasesfor use in surgery; pharmaceutical preparation for treating hepatopathyneoplasmcancertumorsneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseasesfor use in surgery; chemico-pharmaceutical preparations; chemical preparations for medical purposesfor treating hepatopathyneoplasmcancertumorsneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseasesfor use in surgery; prepared Chinese medicineherbal extracts for the treatment of hepatopathyneoplasmcancertumorsneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseasesfor use in surgery; biomedicine preparations for the treatment of hepatopathyneoplasmcancertumoursneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseases and for use in surgery; medicated candy; albuminous foodstuffs being dietetic foods adapted for medical purposes

Class 10

Medical apparatus and instruments for use in surgery; diagnostic apparatus for medical purposesspecifically for the detection of heart diseases; gastroscopes; mirrors for surgeons; testing apparatus for medical purposesapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; endoscopy cameras for medical purposes; surgical apparatus and instruments; suture materials; cooling patches for medical purposes; surgical implants comprised of artificial materials

Class 35

Retail store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceuticalsveterinary and sanitary preparations and medical supplies; search engine optimization for sales promotion; retail store or wholesale store services for featuring pharmaceuticals

Publications

History of USPTO decisions and trademark events.

38 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/26/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/26/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/26/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/26/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/16/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/16/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/16/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/18/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/26/2020

FIMP

FINAL DISPOSITION PROCESSED

09/25/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/26/2020

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/16/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

05/26/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/10/2020

PUBO

PUBLISHED FOR OPPOSITION

03/10/2020

GPNX

NOTIFICATION PROCESSED BY IB

03/07/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/19/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/19/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/19/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/04/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/19/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/19/2019

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

12/19/2019

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

11/21/2019

GNFR

FINAL REFUSAL E-MAILED

11/21/2019

CNFR

FINAL REFUSAL WRITTEN

11/21/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/25/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/24/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/24/2019

RFNT

REFUSAL PROCESSED BY IB

09/13/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/26/2019

RFRR

REFUSAL PROCESSED BY MPU

08/26/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/04/2019

CNRT

NON-FINAL ACTION WRITTEN

08/03/2019

DOCK

ASSIGNED TO EXAMINER

07/31/2019

MAFR

APPLICATION FILING RECEIPT MAILED

07/19/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/15/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/11/2019

Continuous trademark protection

Get notified about every new filing that threatens HAISCO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.